Pembrolizumab as first-line treatment for metastatic uveal melanoma-Reference-Cited by-同舟云学术

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Published:2019-06-07 Issue:7 Volume:68 Page:1179-1185
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Rossi Ernesto,Pagliara Monica Maria,Orteschi Daniela,Dosa Tommaso,Sammarco Maria Grazia,Caputo Carmela Grazia,Petrone Gianluigi,Rindi Guido,Zollino Marcella,Blasi Maria Antonietta,Cassano Alessandra,Bria Emilio,Tortora Giampaolo,Schinzari Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-019-02352-6.pdf

Reference29 articles.

1. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW (2005) Incidence of non cutaneous melanomas in the US. Cancer 103:1000–1007. https://doi.org/10.1002/cncr.20866

2. Kujala E, Makitie T, Kivela T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Investig Ophthalm Vis Sci 44:4651–4659. https://doi.org/10.1167/iovs.03-0538

3. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB (2005) Variates of survival in metastatic uveal melanoma. J Clin Oncol 23:8076–8080. https://doi.org/10.1200/JCO.2005.02.6534

4. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD et al (2005) Development of metastatic disease after enrollment in the COMS trial for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No 26. Arch Ophthalmol 123:1629–1643. https://doi.org/10.1001/archopht.123.12.1639

5. Agarwala SS, Eggermont AM, O’Day S, Zager JS (2014) Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer 120:781–789. https://doi.org/10.1002/cncr.28480

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Molecular and Genetic Research on Uveal Melanoma;Cells;2024-06-12

2. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients;Scientific Reports;2024-04-21

3. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis;Scientific Reports;2024-04-03

4. The Future of Checkpoint Inhibitors in Uveal Melanoma: A Narrative Review;Ophthalmology and Therapy;2024-03-18

5. Targeted therapy in ophthalmic oncology: The current status;Asia-Pacific Journal of Ophthalmology;2024-03